国际肿瘤学杂志
國際腫瘤學雜誌
국제종류학잡지
JOURNAL OF INTERNATIONAL ONCOLOGY
2013年
4期
294-297
,共4页
脂肪肉瘤%外科手术%药物疗法%放射疗法%靶向治疗
脂肪肉瘤%外科手術%藥物療法%放射療法%靶嚮治療
지방육류%외과수술%약물요법%방사요법%파향치료
Liposarcoma%Surgical procedures,operative%Drug therapy%Radiotherapy%Targeted therapy
脂肪肉瘤是最多见的软组织肿瘤,其临床表现、病理和分子特征多种多样.手术治疗仍然是治疗的基础,是惟一提供治愈可能的方法.分子生物学的发展,相关分子通路、癌基因及抑癌基因等的发现,使靶向药物治疗脂肪肉瘤在将来变为可能.
脂肪肉瘤是最多見的軟組織腫瘤,其臨床錶現、病理和分子特徵多種多樣.手術治療仍然是治療的基礎,是惟一提供治愈可能的方法.分子生物學的髮展,相關分子通路、癌基因及抑癌基因等的髮現,使靶嚮藥物治療脂肪肉瘤在將來變為可能.
지방육류시최다견적연조직종류,기림상표현、병리화분자특정다충다양.수술치료잉연시치료적기출,시유일제공치유가능적방법.분자생물학적발전,상관분자통로、암기인급억암기인등적발현,사파향약물치료지방육류재장래변위가능.
Liposarcoma is the most common soft tissue sarcoma.Liposarcoma is widely diverse in the clinical,pathological,and molecular characteristics.Surgery is still the mainstay of liposarcoma therapy and the only cure way.With the development of molecular biology,as well as the discovery of molecular pathways,oncogenes and anti-oncogenes,it is possible to treat liposarcoma with targeted drugs.
